Get the Stockscreener App
5.19
0.19%
-0.00
Candel Therapeutics Inc stock is traded at $5.19, with a volume of 161.59K.
It is down -0.19% in the last 24 hours and down -22.11% over the past month.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
See More
Previous Close:
$5.19
Open:
$5.15
24h Volume:
161.59K
Relative Volume:
0.66
Market Cap:
$166.52M
Revenue:
$124.00K
Net Income/Loss:
$-37.94M
P/E Ratio:
-4.6757
EPS:
-1.11
Net Cash Flow:
$-34.70M
1W Performance:
-5.04%
1M Performance:
-22.11%
6M Performance:
-42.57%
1Y Performance:
+667.29%
1-Day Range:
$5.12
$5.255
1-Week Range:
$5.12
$5.50
52-Week Range:
$0.75
$14.30
Candel Therapeutics Inc Stock (CADL) Company Profile
Name
Candel Therapeutics Inc
Sector
Industry
Phone
617-916-5445
Address
117 KENDRICK STREET, NEEDHAM
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Aug-23-21 | Initiated | Credit Suisse | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
| Aug-23-21 | Initiated | UBS | Buy |
Candel Therapeutics Inc Stock (CADL) Latest News
Candel Therapeutics eyes new indication for CAN-3110 in melanoma following positive preclinical results - Proactive Investors USA
Candel Therapeutics to Present Preclinical Data at SITC - GlobeNewswire
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma - StockTitan
Candel Therapeutics: A Low-Price Oncolytic Virus Plays Further Along Than You Think - Seeking Alpha
Candel Therapeutics Advances in Cancer Treatment Trials - Yahoo Finance
Candel Therapeutics Showcases Innovative Cancer Therapy - GlobeNewswire
Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC) - StockTitan
Candel Therapeutics Prices IPO At $8/Share - RTTNews
Where are the Opportunities in (CADL) - Stock Traders Daily
Candel Therapeutics Share PriceCADL, RNS News, Articles, Quotes, & Charts (NASDAQ:CADL) - Proactive Investors USA
Candel Therapeutics Poised for Breakthrough in Cancer Therapies, Key Trials to Read Out by Year-End - Proactive Investors UK
Candel Therapeutics, Inc. (NASDAQ:CADL) Short Interest Update - MarketBeat
(CADL) Trading Advice - Stock Traders Daily
Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 15,000 Shares - MarketBeat
Candel therapeutics investor sells $243,834 in stock By Investing.com - Investing.com South Africa
How To Trade (CADL) - Stock Traders Daily
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting - The Manila Times
Candel Therapeutics to Present Preclinical Data on - GlobeNewswire
Candel therapeutics insider sells shares worth over $240k By Investing.com - Investing.com South Africa
Candel therapeutics insider sells shares worth over $240k - Investing.com India
Candel Therapeutics, Inc. (NASDAQ:CADL) Major Shareholder Estuardo Aguilar-Cordova Sells 1,800 Shares - MarketBeat
Citigroup Raises Cogent Biosciences (NASDAQ:COGT) Price Target to $15.00 - Defense World
Citi raises Cogent price target on bezuclastinib potential - Investing.com India
Deeper Dive: Understanding Cg Oncology Inc. (CGON) Through its Various Ratios - The Dwinnex
(CADL) Proactive Strategies - Stock Traders Daily
Gaining Ground: Cogent Biosciences Inc (COGT) Closes Lower at 10.65, Down -3.01 - The Dwinnex
Cg Oncology Inc. [CGON] Stock sold by Insider Song Hong Fang for $23.0 million - Knox Daily
Capricor Therapeutics Shares Rise in Premarket on Plans to File Application for Deramiocel - MarketWatch
Cintas Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Kayne Anderson Rudnick Investment Management LLC Trims Holdings in Copart, Inc. (NASDAQ:CPRT) - Defense World
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Cadence Design Systems Inc. stock rises Monday, still underperforms market - MarketWatch
Xponance Inc. Has $24.15 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Hood River Capital Management LLC Has $13.71 Million Holdings in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Mizuho recommends buying Corbus following its drop post-Novo's obesity data (NASDAQ:CRBP) - Seeking Alpha
Is it possible to buy Candel Therapeutics Inc(CADL) shares at a good price now? - US Post News
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World
Mount Yale Investment Advisors LLC Sells 2,003 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Kayne Anderson Rudnick Investment Management LLC Trims Stake in Cadence Design Systems, Inc. (NASDAQ:CDNS) - Defense World
Revenues Working Against Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Share Price Following 27% Dive - Simply Wall St
Pacer Advisors Inc. Boosts Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN) - MarketBeat
Sands Capital Ventures LLC Cuts Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - Defense World
Sands Capital Ventures LLC Trims Stock Position in Candel Therapeutics, Inc. (NASDAQ:CADL) - MarketBeat
Davidson Capital Management Inc. Buys 11,978 Shares of Copart, Inc. (NASDAQ:CPRT) - Defense World
Did Candel Therapeutics Inc (CADL) perform well in the last session? - US Post News
Corbus drops after rival Novo Nordisk reports obesity drug data - XM
Choreo LLC Purchases Shares of 23,033 Coty Inc. (NYSE:COTY) - Defense World
Cadence design systems director sells $414k in company stock - Investing.com
Sienna Gestion Trims Stake in Copart, Inc. (NASDAQ:CPRT) - Defense World
Catalyst Pharmaceuticals stock hits 52-week high at $20.88 - Investing.com
Candel Therapeutics Inc Stock (CADL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Candel Therapeutics Inc Stock (CADL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Aguilar-Cordova Estuardo | 10% Owner |
Oct 14 '24 |
Sale |
6.02 |
15,000 |
90,300 |
929,873 |
| Aguilar-Cordova Estuardo | 10% Owner |
Oct 15 '24 |
Sale |
6.03 |
10,412 |
62,784 |
919,461 |
| Aguilar-Cordova Estuardo | 10% Owner |
Oct 02 '24 |
Sale |
6.92 |
26,988 |
186,757 |
961,673 |
| Aguilar-Cordova Estuardo | 10% Owner |
Oct 03 '24 |
Sale |
6.85 |
1,800 |
12,330 |
959,873 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):